Blue Crest Capital Management LTD Gilead Sciences, Inc. Transaction History

Blue Crest Capital Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $631,074 - $707,676	-10,200 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $637,806 - $714,510	10,200 New	10,200 $663,000
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $206,017 - $268,837	-3,403 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $242,565 - $268,564	3,403 New	3,403 $263,000

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.